Funding and debt▼ Bearish for Natco Pharma

Natco Pharma approves rights issue to raise up to ₹1,279 crore

2 sources · first seen 12:04 25 Sept · updated 14:16 25 Sept

The brief

Written from 2 reports · check the source before you trade

The issue will offer up to 1,70,58,082 shares at ₹750 each
Eligible shareholders can subscribe for two shares per 21 held
The rights issue may dilute non-participating shareholders; Natco Pharma investors face the funding decision

the session the news first traded, and since

Stock	Traded	That day	vs Nifty	Volume	Since
NATCOPHARM	Fri, 25 Sept	−0.3%	−0.7%	0.9×	−0.3% · Nifty +0.3%

✓ Classifier read this as negative; NATCOPHARM fell 0.7% against the Nifty on the day it traded.

Pick a tag to see all its stories

2 reports · earliest 12:04